We sought to determine if chronic rhinosinusitis (CRS) patients with nasal polyps (CRSwNP) differentially perceived CRS symptom burden compared to patients without nasal polyps (CRSsNP) and to what extent CRS symptom severity was associated with quality of life (QOL) and patient-reported symptom control in the 2 groups.
Methods
A total of 600 patients (266 CRSwNP and 334 CRSsNP) presenting with CRS were recruited. CRS symptom burden was assessed with the 22-item Sinonasal Outcome Test (SNOT-22). SNOT-22 nasal, sleep, ear/facial discomfort, and emotional subdomain scores were calculated. General health-related QOL was assessed with the visual analog scale of the 5-dimensional EuroQol questionnaire (EQ-5D VAS). Patients rated their CRS symptom control on a 5-point scale.
Results
SNOT-22 scores did not differ between CRSwNP (mean: 35.6) and CRSsNP (mean: 36.3). There were no differences in nasal, sleep, and emotional subdomains of the SNOT-22. CRSsNP had higher (P = .003) ear/facial subdomain scores than CRSwNP, while CRSwNP reported greater hyposmia (P < .001). EQ-5D VAS was significantly lower (P = .011) in CRSsNP (mean: 68.9) compared to CRSwNP (mean: 73.2). However, CRSwNP patients reported significantly less symptom control, compared to CRSsNP, in association with nasal and emotional symptoms.
Conclusion
CRSwNP and CRSsNP have differences in symptom profile, effect on health-related QOL, and patient-perceived symptom control. CRSsNP experience significantly greater burden of ear/facial discomfort, while CRSwNP report greater hyposmia. Although CRSsNP reports lower general health-related QOL overall, CRSwNP patients had lower levels of CRS symptom control for every incremental increase in symptom burden suggesting greater sensitivity/intolerance to CRS symptoms.
FokkensWJLundVJMullolJ, et al.European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;
23:298.
2.
OrlandiRRKingdomTTHwangPH, et al.International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol. 2016;
6Suppl 1:S209.
3.
AlobidIGuilemanyJMMullolJ.The impact of chronic rhinosinusitis and nasal polyposis in quality of life.Front Biosci (Elite Ed). 2009;
1:269–276.
4.
HoehleLPPhillipsKMBergmarkRWCaradonnaDSGraySTSedaghatAR.Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology. 2016;
54:316–322.
5.
PhillipsKMHoehleLPBergmarkRW, et al.Chronic rhinosinusitis severity is associated with need for asthma-related systemic corticosteroids. Rhinology. 2017;
55:211–217.
6.
PhillipsKMHoehleLPBergmarkRWCaradonnaDSGraySTSedaghatAR.Acute exacerbations mediate quality of life impairment in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2017;
5:422–426.
7.
PhillipsKMHoehleLPCaradonnaDSGraySTSedaghatAR.Association of severity of chronic rhinosinusitis with degree of comorbid asthma control. Ann Allergy Asthma Immunol. 2016;
117:651–654.
8.
RudmikL.Economics of chronic rhinosinusitis.Curr Allergy Asthma Rep. 2017;
17:5.
9.
TecimerSHKasapogluFDemirULOzmenOACoskunHBasutO.Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps. Eur Arch Otorhinolaryngol. 2015;
272:915–921.
10.
TomassenPVandeplasGVan ZeleT, et al.Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;
137:1449–1456.e1444.
11.
Van ZeleTClaeysSGevaertP, et al.Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;
61:1280–1289.
12.
TanBKKlinglerAIPoposkiJA, et al.Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. J Allergy Clin Immunol. 2017;
139(2):699–703.e7.
13.
KonigKKlemensCHaackM, et al.Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys. Allergy Asthma Clin Immunol. 2016;
12:19.
14.
AlobidIBenitezPValeroA, et al.The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis.Otolaryngol Head Neck Surg. 2006;
134:609–612.
15.
BenjaminMRStevensWWLiN, et al.Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting. J Allergy Clin Immunol Pract. 2019;
7:1010–1016.
16.
KhanAVandeplasGHuynhTMT, et al.The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;
57:32–42.
17.
KhanAHuynhTMTVandeplasG, et al.The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019;
57:343–351.
18.
FalcoJJThomasAJQuinX, et al.Lack of correlation between patient reported location and severity of facial pain and radiographic burden of disease in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;
6:1173–1181.
19.
SpethMMGaudinRAHoehleLP, et al.Reciprocal predictive accuracy of sinonasal symptom severity, nasal endoscopy, and frequency of past chronic rhinosinusitis exacerbations. Otolaryngol Head Neck Surg. 2018;
159:766–773.
20.
PhillipsKMBergmarkRWHoehleLP, et al.Differential perception and tolerance of chronic rhinosinusitis symptoms as a confounder of gender-disparate disease burden. Int Forum Allergy Rhinol. 2019;
9:1119–1124.
21.
SedaghatARHoehleLPGrayST.Chronic rhinosinusitis control from the patient and physician perspectives. Laryngoscope Investig Otolaryngol. 2018;
3:419–433.
22.
BanoubRGHoehleLPPhillipsKM, et al.
Depressed mood modulates impact of chronic rhinosinusitis symptoms on quality of life. J Allergy Clin Immunol Pract. 2018;
6(6):2098–2105.
23.
BanerjiAPiccirilloJFThawleySE, et al.Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol. 2007;
21:19–26.
24.
RosenfeldRMPiccirilloJFChandrasekharSS, et al.Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;
152:S39.
25.
HoehleLPPhillipsKMCaradonnaDSGraySTSedaghatAR.A contemporary analysis of clinical and demographic factors of chronic rhinosinusitis patients and their association with disease severity. Ir J Med Sci. 2018;
187:215–221.
26.
PhillipsKMHoehleLBergmarkRWCaradonnaDSGraySTSedaghatAR.Reversal of smoking effects on chronic rhinosinusitis after smoking cessation. Otolaryngol Head Neck Surg. 2017;
157:737–742.
27.
HopkinsCGillettSSlackRLundVJBrowneJP.Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;
34:447–454.
28.
HopkinsCHettigeRSoni-JaiswalA, et al.CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis. Rhinology. 2018;
56:22–32.
29.
FengALWeselyNCHoehleLP, et al.A validated model for the 22-item Sino-Nasal Outcome Test subdomain structure in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;
7:1140–1148.
30.
EuroQolG.EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;
16:199–208.
31.
HoehleLPPhillipsKMSpethMMCaradonnaDSGraySTSedaghatAR.Responsiveness and minimal clinically important difference for the EQ-5D in chronic rhinosinusitis. Rhinology. 2019;
57(2):110–116.
32.
RudmikLHopkinsCPetersASmithTLSchlosserRJSolerZM.Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy Clin Immunol. 2015;
136:1532–1540.e2.
33.
GraySTHoehleLPPhillipsKMCaradonnaDSSedaghatAR.Patient-reported control of chronic rhinosinusitis symptoms is positively associated with general health-related quality of life. Clin Otolaryngol. 2017;
42:1161–1166.
34.
GraySTPhillipsKMHoehleLPCaradonnaDSSedaghatAR.The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of chronic rhinosinusitis symptomatology. Int Forum Allergy Rhinol. 2017;
7:945–951.
35.
PhillipsKMBergmarkRWHoehleLP, et al.Differential perception and tolerance of chronic rhinosinusitis symptoms as a confounder of gender-disparate disease burden.Int Forum Allergy Rhinol. 2019;
9(10):1119–1124.
36.
SpethMMHoehleLPPhillipsKMCaradonnaDSGraySTSedaghatAR.Changes in chronic rhinosinusitis symptoms differentially associate with improvement in general health-related quality of life. Ann Allergy Asthma Immunol. 2018;
121(2):195–199.
37.
SpethMMHoehleLPPhillipsKMCaradonnaDSGraySTSedaghatAR.Treatment history and association between allergic rhinitis symptoms and quality of life. Ir J Med Sci. 2019;
188(2):703–710.
38.
ErskineSHopkinsCKumarN, et al.A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes. Rhinology. 2016;
54:311–315.
39.
Sahlstrand-JohnsonPOhlssonBVon BuchwaldCJannertMAhlner-ElmqvistM. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology. 2011;
49:420–428.
40.
DealRTKountakisSE.Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes.Laryngoscope. 2004;
114:1932–1935.
41.
ZhengYZhaoYLvD, et al.Correlation between computed tomography staging and quality of life instruments in patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2010;
24:e41–e45.
42.
ErskineSEHopkinsCClarkA, et al.Chronic rhinosinusitis and mood disturbance. Rhinology. 2017;
55:113–119.
43.
ChowdhuryNIMaceJCBodnerTE, et al.Does medical therapy improve SinoNasal Outcomes Test-22 domain scores? An analysis of clinically important differences. Laryngoscope. 2019;
129:31–36.
44.
SedaghatAR.Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures. Otolaryngol Head Neck Surg. 2019;
161(4):551–560.
45.
HoehleLPPhillipsKMSpethMMCaradonnaDSGraySTSedaghatAR.Responsiveness and minimal clinically important difference for the EQ-5D in chronic rhinosinusitis. Rhinology. 2019;
57:110–116.
46.
PhillipsKMHoehleLPCaradonnaDSGraySTSedaghatAR.Minimal clinically important difference for the 22-item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis. Clin Otolaryngol. 2018;
43:1328–1334.
47.
GraySTPhillipsKMHoehleLP, et al.Utilization patterns of systemic corticosteroid use for chronic rhinosinusitis. Acta Otolaryngol. 2018;
138:153–158.
